New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S4323

Introduced
5/12/25  

Caption

Requires health insurance coverage of screening for Alzheimer's disease and related disorders for certain covered persons.

Impact

If enacted, S4323 will require health insurance policies—including those provided by hospital service corporations, medical service corporations, health maintenance organizations, and state health benefits programs—to include coverage for Alzheimer's disease screening. These provisions mean that insurers must treat screening for Alzheimer's with the same level of importance as other health conditions, thus enhancing the healthcare safety net for the aging population in New Jersey.

Summary

Senate Bill S4323, introduced in New Jersey on May 12, 2025, mandates that health insurance carriers provide coverage for screening for Alzheimer's disease and related disorders for individuals aged 65 and older. The bill intends to ensure that older adults have access to necessary health screenings, which can facilitate early diagnosis and management of Alzheimer’s disease, thereby potentially improving patient outcomes and quality of life.

Contention

The bill may face scrutiny regarding its implications on insurance premiums and healthcare costs. While proponents argue that the legislation will reduce long-term healthcare expenses by promoting early detection and intervention, critics may raise concerns about the financial burden on insurers and how these costs will ultimately be passed on to consumers. Thus, the dialogue surrounding S4323 involves balancing the healthcare needs of seniors with the economic realities of the health insurance market.

Companion Bills

NJ A5341

Same As Requires health insurance coverage of screening for Alzheimer's disease and related disorders for certain covered persons.

Previously Filed As

NJ S2871

Requires health insurance coverage of screening for Alzheimer's disease and related disorders for certain covered persons.

NJ A2116

Requires health insurance coverage of screening for Alzheimer's disease and related disorders for certain covered persons.

NJ S4073

Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.

NJ A5062

Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.

NJ S598

Requires health insurance coverage for certain neurological diseases.

NJ A3246

Requires health insurance coverage for certain neurological diseases.

NJ A4915

Requires health insurance coverage for early-stage kidney disease screening without cost sharing.

NJ S4243

Requires health insurance coverage for early-stage kidney disease screening without cost sharing.

NJ SB1314

Health insurance; coverage requirements for prostate cancer screenings.

NJ A2649

Requires health insurance coverage for annual mental health screening.

Similar Bills

NJ S1243

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ A1557

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ S1250

Requires DHS to establish Alzheimer's disease public awareness campaign.

WV HB4474

Extending the Alzheimer’s Disease and Other Dementia Advisory Council sunset date.

WV SB604

Extending Alzheimer's Disease and Other Dementia Advisory Council sunset date

HI SCR203

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.

HI HR30

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.

HI SR163

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.